Discontinuation of statin therapy following an acute myocardial infarction: a population-based study

Area of Science:

• Cardiology
• Pharmacology
• Public Health

Background:

• Statins are proven to reduce mortality following acute myocardial infarction (AMI).
• The impact of altering statin use patterns, specifically discontinuation, on post-AMI survival remains unclear.

Purpose of the Study:

• To investigate the association between different statin use patterns and mortality in patients after AMI.
• To quantify the risk associated with stopping statin therapy post-AMI.

Main Methods:

• A population-based cohort study using the UK General Practice Research Database (GPRD) from 2002-2004.
• Included 9939 AMI survivors followed for 1 year post-AMI (90 days after the event).
• Categorized patients into non-users, continuous users, starters, and stoppers of statins; analyzed 1-year all-cause mortality using Cox proportional hazards models.

Main Results:

• Statin discontinuation post-AMI was observed in 22.7% of patients.
• Compared to non-users, statin stoppers had a significantly higher adjusted hazard ratio for 1-year mortality (1.88; 95% CI: 1.13-3.07).
• Statin starters showed a reduced mortality risk (HR: 0.72; 95% CI: 0.57-0.90).

Conclusions:

• Discontinuation of statins after AMI, though infrequent, is associated with increased all-cause mortality.
• This association may reflect a biological rebound effect or a risk-treatment mismatch.
• Judicious clinical supervision is recommended when considering the withdrawal of statin therapy in AMI survivors.